美女高潮喷水白浆后入在线观看_出a级黑粗大硬长爽猛视频_qvod日韩伦理电影_亚洲自偷自拍三级_成人黄片视频_精品综合无码在线观看_亚洲综合无码中文字幕伊人_亚洲男人天堂最新版_夫洗澡公强我了60分钟_免费看又爽又黄又猛的视频

EGF樣域蛋白7(EGFL7)多克隆抗體

Polyclonal Antibody to EGF Like Domain Protein, Multiple 7 (EGFL7)

ZNEU1; MEGF7; Zneu1; Vascular endothelial statin; EGF Like Domain Containing 7; Epidermal growth factor-like protein 7; Multiple epidermal growth factor-like domains protein 7

  • EGF樣域蛋白7(EGFL7)多克隆抗體 產(chǎn)品包裝(模擬)
  • EGF樣域蛋白7(EGFL7)多克隆抗體 產(chǎn)品包裝(模擬)
  • Certificate 通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對(duì)EGFL7的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別EGFL7。

用法

免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學(xué):5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶(hù)決定。

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào) 適用物種:Mus musculus (Mouse,小鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
URPL643Mu01 EGF樣域蛋白7(EGFL7)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPL643Mu02 EGF樣域蛋白7(EGFL7)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAL643Mu02 EGF樣域蛋白7(EGFL7)多克隆抗體 WB; IHC; ICC; IP.
UPAL643Mu01 EGF樣域蛋白7(EGFL7)多克隆抗體 WB; IHC
USEL643Mu EGF樣域蛋白7(EGFL7)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULML643Mu EGF樣域蛋白7(EGFL7)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Scientific Reports Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab [PMC5443778]
Scientific Reports Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. [pubmed:28539619]
International Journal of Clinical and Experimental Pathology EGF like domain multiple 7 regulates the migration and invasion of prostate cancer cells [ISSN:1936-2625]
Cancer Drug Resist MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy []
留言咨詢(xún)